Why are patents on genetically modified seeds controversial?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

A step-by-step diagram shows donor DNA and vector DNA cut with restriction enzymes to create overhangs, mixed and sealed with ligase to form recombinant DNA, which is introduced into bacterial cells. The recombinant DNA replicates as the cells divide, producing clones. — biotechnology Steps involved in the engineering of a recombinant DNA molecule.

Patents on genetically modified (GMO) seeds are a subject of significant debate within biotechnology. While the legal framework for patentable living organisms was established in 1980, the application of these rights to crops has sparked ongoing ethical and social concerns.1

The controversy primarily centers on the following issues:

Corporate Control: Critics argue that patents grant a small number of corporations excessive control over the global seed supply, which can limit competition and influence agricultural practices.1
Farmers’ Rights: Patent restrictions often prevent farmers from saving or replanting seeds from season to season, a traditional practice that is now legally restricted by intellectual property agreements.1
Food Security and Access: There are concerns that patent-protected technology may limit equitable access to agricultural innovations, potentially impacting food security in vulnerable regions.1

Ethically, these debates highlight a fundamental tension between incentivizing innovation through intellectual property and ensuring that essential agricultural resources remain accessible to the public. These competing interests continue to shape global regulatory policies and public discourse regarding the role of biotechnology in our food systems.1